InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,169.01
(
-0.36%
)
US TECH 100
17,508.00
(
-0.60%
)
Dow Jones
38,877.01
(
-0.02%
)
Brent Oil
82.18
(
-0.83%
)
Bitcoin
61,899.36
(
-0.70%
)
Post# of 340
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

57_2001

Send PM Follow Ignore
Followers 3
Posts 537
Boards Moderated 0
Alias Born 03/05/2017

57_2001

Re: None

Wednesday, 05/18/2022 9:19:36 AM

Wednesday, May 18, 2022 9:19:36 AM

Post# of 340
rucosopasem is in early testing,

dealing with pancreatic cancer, could be the real gem here, if successful. IMO.

https://www.bizjournals.com/philadelphia/news/2022/05/16/galera-therapeutics-malvern-nda-cancer-mucostitis.html?ana=yahoo

more info june 3 at asco.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent GRTX News
More GRTX News
InvestorsHub NewsWire

FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

Start posting your company's news
Only $200 per official company press release!